FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> Generics | Roche | Watson Pharmaceuticals

ALSO NOTED: States sued over prescription-tracking law; Watson challenges Warner Chilcott on birth control pill;

Tools

> Three health information companies are suing the states of Vermont and Maine to block laws that would prevent drug makers from tracking individual scrips written by individual doctors; the privacy laws are set to take effect January 1. Release

> Watson Pharmaceuticals has asked the FDA to approve its copycat of Femcon, a Warner Chilcott birth-control pill; Warner Chilcott, meanwhile, sued the generics maker to block the drug. Release

> Contract manufacturer SAFC says it's planning to add conjugation capabilities to its Missouri plant, aiming to target pharma clients developing novel anti-cancer drugs. Report

> The troubled PDL BioPharma has put out the 'for sale' sign in an attempt to find a buyer for the company as a whole or of its key assets. Report

> Perlegen Sciences and Roche's 454 Life Sciences have teamed up to conduct large scale genetic re-sequencing in DNA samples collected from people with specific responses to an undisclosed class of drug. Report

And Finally... Antibiotics might fight stroke, too: A small new study showed that minocycline administered within 24 hours of a stroke reduced brain damage and physical impairment. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:
Be the first to comment
More stories about Generics   Roche   Watson Pharmaceuticals  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.